Algorae Pharmaceuticals Ltd (LVCLF): Parkinson's trial resumes patient recrui...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	41
Posts	2953
Boards Moderated	4
Alias Born	05/19/2010

SJOGRINGO

Re: None

Sunday, 06/22/2014 10:23:53 PM

Sunday, June 22, 2014 10:23:53 PM

Parkinson's trial resumes patient recruitment

http://www.lctglobal.com/upload/news/pdfs/140623%20LCT%20Parkinsons%20trial%20resumes%20patient%20recruitment.pdf

Living Cell Technologies Limited has received the necessary regulatory approval to resume recruitment of the remaining three patients in the Phase I/IIa clinical trial of NTCELL® in Parkinson’s disease. The trial was paused in December last year while the company completed internal and external audit and regulatory processes.

Dr Ken Taylor, NTCELL Program Director and Acting Chief Executive, is pleased that patient recruitment in the clinical trial of NTCELL for Parkinson’s can resume.

“The completion of the clinical trial is an initial step in progressing NTCELL to commercialization as the first disease modifying treatment for Parkinson’s disease.”

Read the full announcement here.

Never buy/sell based on my posts.My posts are opinions
only.My positions are subject to change W/O
notice NOTICE: NSA reportedly monitors,copies,and
captures IP address of electronic communications to and from the USA.